OBJECTIVE: To investigate the effect of maternal body mass index (BMI) on minor complications, associated additional medication use during pregnancy and the consequent cost implications. DESIGN: Retrospective analysis of case notes. SETTING: Labour wards, tertiary referral hospital, Royal Infirmary Edinburgh, UK. Population Six hundred and fifty-one women with a singleton pregnancy over four separate time periods in 2007 and 2008. METHODS: Descriptive statistics, univariate and multivariate logistic regression analysis and cost analysis using standard techniques and inflation indices. MAIN OUTCOME MEASURES: Minor complications, use of medications during pregnancy and consequent incremental costs from the perspective of the National Health Service (NHS). RESULTS: 42.4% of women were overweight or obese (BMI > or = 25 kg/m(2)). Higher BMI during the first trimester (BMI > or = 30 kg/m(2) compared with BMI < 25 kg/m(2)) was associated with an increased risk of minor complications including symphysis pubis dysfunction (OR 3.97; 95% CI 2.19-7.18), heartburn (OR 2.65; 95% CI 1.42-4.94) and chest infection (OR 8.71; 95% 2.20-34.44) and with drugs used to treat these complications including Gaviscon (OR 3.52; 95% CI 1.78-6.96). The mean incremental (additional) NHS costs per woman for treating minor complications increased with maternal BMI were 15.45 pounds/woman, 17.64 pounds/woman and 48.66 pounds/woman for BMI < 25 kg/m(2), BMI > or = 25 to <30 kg/m(2) and BMI > or = 30 kg/m(2) respectively. CONCLUSIONS: Increased maternal BMI is associated with increased risk of developing minor complications during pregnancy; use of medications associated with treating these conditions and has significant NHS costs.
OBJECTIVE: To investigate the effect of maternal body mass index (BMI) on minor complications, associated additional medication use during pregnancy and the consequent cost implications. DESIGN: Retrospective analysis of case notes. SETTING: Labour wards, tertiary referral hospital, Royal Infirmary Edinburgh, UK. Population Six hundred and fifty-one women with a singleton pregnancy over four separate time periods in 2007 and 2008. METHODS: Descriptive statistics, univariate and multivariate logistic regression analysis and cost analysis using standard techniques and inflation indices. MAIN OUTCOME MEASURES: Minor complications, use of medications during pregnancy and consequent incremental costs from the perspective of the National Health Service (NHS). RESULTS: 42.4% of women were overweight or obese (BMI > or = 25 kg/m(2)). Higher BMI during the first trimester (BMI > or = 30 kg/m(2) compared with BMI < 25 kg/m(2)) was associated with an increased risk of minor complications including symphysis pubis dysfunction (OR 3.97; 95% CI 2.19-7.18), heartburn (OR 2.65; 95% CI 1.42-4.94) and chest infection (OR 8.71; 95% 2.20-34.44) and with drugs used to treat these complications including Gaviscon (OR 3.52; 95% CI 1.78-6.96). The mean incremental (additional) NHS costs per woman for treating minor complications increased with maternal BMI were 15.45 pounds/woman, 17.64 pounds/woman and 48.66 pounds/woman for BMI < 25 kg/m(2), BMI > or = 25 to <30 kg/m(2) and BMI > or = 30 kg/m(2) respectively. CONCLUSIONS: Increased maternal BMI is associated with increased risk of developing minor complications during pregnancy; use of medications associated with treating these conditions and has significant NHS costs.
Authors: Yassaman Vafai; Edwina H Yeung; Rajeshwari Sundaram; Melissa M Smarr; Nicole Gerlanc; William A Grobman; Daniel Skupski; Edward K Chien; Stefanie N Hinkle; Roger B Newman; Deborah A Wing; Angela C Ranzini; Anthony Sciscione; Jagteshwar Grewal; Cuilin Zhang; Katherine L Grantz Journal: J Matern Fetal Neonatal Med Date: 2021-03-11
Authors: Fiona C Denison; Heather MacGregor; Laura I Stirrat; Kerrie Stevenson; Jane E Norman; Rebecca M Reynolds Journal: BMJ Open Date: 2017-06-21 Impact factor: 2.692
Authors: Shareen Forbes; Sarah M Barr; Rebecca M Reynolds; Scott Semple; Calum Gray; Ruth Andrew; Fiona C Denison; Brian R Walker; Jane E Norman Journal: Diabetologia Date: 2015-08-07 Impact factor: 10.122
Authors: Kelly L Morgan; Muhammad A Rahman; Steven Macey; Mark D Atkinson; Rebecca A Hill; Ashrafunnesa Khanom; Shantini Paranjothy; Muhammad Jami Husain; Sinead T Brophy Journal: BMJ Open Date: 2014-02-27 Impact factor: 2.692
Authors: Patrick S Moran; Francesca Wuytack; Michael Turner; Charles Normand; Stephanie Brown; Cecily Begley; Deirdre Daly Journal: PLoS One Date: 2020-01-16 Impact factor: 3.240